Guidelines, Atrial fibrillation, Anticoagulation, Vitamin K antagonists, Non-vitamin K antagonist oral anticoagulants, Left atrial appendage occlusion, Rate control, Cardioversion, Rhythm control, Antiarrhythmic drugs, Upstream therapy, Catheter ablation, AF surgery, Valve repair, Pulmonary vein isolation, Left atrial ablation

The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)

Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC

Endorsed by the European Stroke Organisation (ESO)


  • 1 Preamble 5

  • 2 Introduction 7

  • 3 Epidemiology and impact for patients 7

  •  3.1 Incidence and prevalence of atrial fibrillation 7

  •  3.2 Morbidity, mortality, and healthcare burden of atrial fibrillation 7

  •  3.3 Impact of evidence-based management on outcomes in atrial fibrillation...

Article PDF first page preview

Article PDF first page preview
Article PDF first page preview
You do not currently have access to this article.